In infection resistance and disease tolerance to microbial insult, the ligand-activated transcription factor aryl hydrocarbon receptor (AhR) adaptively balances aggressive immune responses (“resistance”) with the host’s ability to withstand the negative effects of infection, namely, immunopathology or damage due to pathogen metabolism and virulence factors (“tolerance”) (3, 4). The gene discussed is AHR; the disease is infection.